Rate of Clinical Trial Enrollment in Patients Treated for DLBCL Within the Veterans Health AdministrationSeptember 2, 2020Oncology
Prostate-Specific Antigen Decline >50% After 4 Weeks of Treatment Is an Indicator of Better Progression Free and Overall Survival Both With Abiraterone and Enzalutamide in Metastatic Castrate Resistant Prostate CancerSeptember 2, 2020OncologyProstate Cancer
Primitive Neuroectodermal Tumor of the Pancreas in Adults; A Rare and Aggressive MalignancySeptember 2, 2020Oncology
Oncology-Palliative Care Collaboration: Impact on Hospice Accession and End-of-Life CareSeptember 2, 2020Oncology
Initiation of Schwartz Rounds at VA Connecticut to Engage Providers and Improve CommunicationSeptember 2, 2020Oncology
In-Depth Look at a Community- Based Population of Multiple Myeloma (MM) Patients Undergoing an in-Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib in the United States (US) MM-6 StudySeptember 2, 2020OncologyMultiple Myeloma
Improving Ototoxicity Monitoring with Cisplatin Therapy at VA Northeast Ohio Healthcare System (VANOHS), An Interdisciplinary Team ApproachSeptember 1, 2020Oncology
Implementing a Navigation Software System Within the Southeast Louisiana Veterans Health Care SystemSeptember 1, 2020Oncology
Implementation of Electronic Antineoplastic Ordering Templates in a Veterans Health SystemSeptember 1, 2020Oncology
Immune-related Adverse Events from Immune Checkpoint Inhibitors: A Retrospective Analysis in a Single- Center Veteran PopulationSeptember 1, 2020Oncology
Hemolytic Anemia Secondary to Methylene Blue Administration in a G6PD Sufficient PatientSeptember 1, 2020Oncology
